Shanghai Silver (2049) Chairman Zhuo Wenheng attended the Taiwan Medical Technology Exhibition today (3rd), and exhibited the Shanghai Silver Endoscope Support Robot Arm, which can be used for minimally invasive surgery such as general surgery, obstetrics and gynecology, and thoracic surgery.
(Photo by reporter Lin Jinghua)
[Reporter Lin Jinghua/Report from Taipei] Zhuo Wenheng, chairman of Shanghai Bank (2049), attended the Taiwan Medical Technology Exhibition today (3rd) and showed the latest medical robot of Shanghai Bank Group. The brand is more competitive, and it has gradually blossomed in Europe, Southeast Asia, China and other places. With the unblocking of the epidemic and the increase in hospital related budgets, the performance of Shangyin's medical robots will grow at least several times next year.
Shangyin has participated in the Taiwan Medical Technology Exhibition for the fifth time this year. Zhuo Wenheng said that Shangyin Group has been in medical related fields for more than 7 years. The main applications of Shangyin Group's medical robots are in rehabilitation and minimally invasive fields. .
Please read on...
Shangyin's "Interactive Lower Limb Rehabilitation Training Machine" has been launched for a long time, and the latest version 2.0 has been released, which can actively guide patients and set appropriate training according to their conditions; currently it has been sold to National Taiwan University General Hospital, Hsinchu Branch Hospital, etc. In the Chinese market, it has also accumulated sales of 100 to 200 units.
As for the "endoscopic support robot arm" is mostly used in minimally invasive surgery such as general surgery, obstetrics and gynecology, and thoracic surgery, Zhuo Wenheng said that the surgical robot can reduce the physical exertion of doctors during surgery and improve safety quality. For surgery, the cost of the patient's surgery is only 1/10 of the original cost.
At present, Zhongshan Affiliated Hospital and Xiuchuan Hospital have adopted it in China. Recently, Kaohsiung Chang Gung is also trialling it. Overseas, it has been sold to Thailand and Vietnam. This year, it will also expand to new European markets such as Poland and France.
Zhuo Wenheng said that after the outbreak of the epidemic, the hospital budget was mostly used for epidemic prevention, and the budget for medical robots was somewhat squeezed out. However, Europe has been unsealed, coupled with the lack of local manpower and high labor costs, the price of medical robots in Shangyin is only in Switzerland and Germany. The other big market is China. China has relaxed the certification for minimally invasive robots this year, and Shangyin has also obtained certification, which will help to promote it in the Chinese market next year.
It is understood that the price of Shanghai Bank’s medical robots is between 2 million and 4 million yuan each, and currently accounts for a relatively low proportion of the group’s revenue. Zhuo Wenheng emphasized that the goal is to continue to expand at home and abroad, and he is also optimistic about the future. In order to meet the needs of the modernization of society and precision medicine, the performance of Shangyin medical robots will grow at least several times next year.
Grasp the pulse of the economy with one hand I subscribe to Free Finance Youtube channel
Already added friends, thank you
Welcome to 【Free Finance】
feel good
Already liked it, thank you.
related news